Press Releases

SFMS Announces Investigation Into Gentiva Health Services’ Acquisition Of Odyssey Healthcare

 

Shepherd, Finkelman, Miller & Shah, LLP (“SFMS”) ( http://www.sfmslaw.com) is investigating the agreement under which Gentiva Health Services (“Gentiva”) (Nasdaq: GTIV) intends to acquire Odyssey Healthcare, Inc. (“Odyssey Healthcare”) (Nasdaq: ODSY). Odyssey Healthcare, based in Dallas, Texas, provides hospice care for patients. Gentiva, with headquarters in Atlanta, Georgia, provides home health services. The agreement, announced on May 24, 2010, would allow Gentiva to acquire Odyssey Healthcare for $27.00 per share, or approximately $1.1 billion for the transaction. SFMS’ investigation of the agreement concerns whether there has been adequate disclosure to shareholders concerning the terms of the acquisition and whether the compensation offered to Odyssey Healthcare shareholders pursuant to the acquisition is adequate. The transaction is expected to be completed in the third quarter of 2010.

If you own shares of Odyssey Healthcare and would like to request additional information about this investigation, please contact Karen M. Leser-Grenon at kleser@sfmslaw.com or toll-free at 866-540-5505 (ext. 206) or Patrick A. Klingman at pklingman@sfmslaw.com or toll-free at 866-540-5505 (ext. 205).

Shepherd, Finkelman, Miller & Shah, LLP ( http://www.sfmslaw.com) is a law firm that represents consumers, fiduciaries, beneficiaries and investors, including institutions and individuals, in class action and other complex litigation, and maintains offices in California, Connecticut, Florida, New Jersey, Pennsylvania and Wisconsin. The firm’s attorneys have experience prosecuting cases on behalf of shareholders in mergers and acquisitions throughout the United States.

Attorney Advertising. Prior results do not guarantee a similar outcome.

>To order reprints of this article, click here: Reprints

Copyright Business Wire 2010

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,393.45 1,310.33 2,827.34 15.81
Oil *
101.78
DOWN
26.41
DOWN
2.99
DOWN
10.02
DOWN
0.44
10 Yr
1.58%
SPDR Gold
151.62
-0.21%
-0.23%
-0.35%
-2.71%
Data delayed 20 minutes

Top Stories and Tools

Articles From

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet